EATONTOWN, N.J.--(BUSINESS WIRE)--Flexible Stenting Solutions Inc. (“FSS”), a leading developer of next generation peripheral arterial, venous, neurovascular and biliary stents, today announced a Series B investment by Goodman Co. Ltd. into FSS. The investment further established Goodman’s commitment to the development and commercialization of FSS’s broad product platform. Goodman is a medical device company based in Nagoya, Japan and is traded as Goodman Co. Ltd. (7535:JASDAQ).
